# Bristol-Myers Squibb Company (BMY) — Q4-2017 Earnings Results

**Report date:** 2018-02-05 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2017

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS, Stock Down 3.97%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | -0.41% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about current market conditions impacting performance. They are focused on adapting strategies to navigate these challenges.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized the need for strategic adjustments moving forward.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report indicates a slight miss on EPS, which contributed to a 3.97% decline in stock price. Investors may be reacting to management's cautious tone regarding market challenges. The lack of guidance could lead to uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2017_